Tipiracil (TPI), one of the key components in TAS-102 (trade name Lonsurf, a mixture of Trifluridine and tipiracil hydrochloride in a 1:0.5 molar ratio), is a potent thymidine phosphorylase (TPase) inhibitor with anticancer activity. TAS-102 has been approved in Japan in 2015.

纯度：≥98%

CAS：183204-74-2